STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1765 by analyst upside · 2026-08-12
PAHC
Phibro Animal Health Corporation
Healthcare · Market Cap $1B · P/E 14.6x
ANALYST PRICE TARGET
+32.0%
implied upside to consensus target
Current Price $34.08
Consensus Target $45.0
Bull Target $58.0
Bear Target $35.0
Analysts Covering 5
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
0
Hold
3
Sell
1
52-Week Low $28.25
52-Week High $60.08
YTD Return -8.0%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 14.6x
Forward P/E 10.2x
EPS (TTM) $2.33
PEG Ratio 1.68
Dividend Yield 1.41%
Revenue (TTM) $1.5B
Profit Margin 6.3%
52-WEEK RANGE
52-Week Low $28.25
52-Week High $60.08
Current Price $34.08
Bear Target $35.0
Bull Target $58.0
● Now $34.08 ● Target $45.0
TRADING DATA
Avg Volume 307K
YTD Return -8.0%
Analyst Count 5
Consensus Hold
Upside to Target +32.0%
Last Updated 2026-08-12

ANALYST SUMMARY

Phibro Animal Health Corporation (PAHC) is currently trading at $34.08 with a Wall Street consensus price target of $45.0, implying potential upside of 32.0% over the next 12 months. 5 analysts currently cover PAHC, with a consensus rating of Hold - 20% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $58.0, while the most cautious has a target of $35.0.

PAHC operates in the Healthcare sector with a market capitalisation of $1B. The stock is down 8.0% year-to-date and is currently trading near the lower end of its 52-week range of $28.25 – $60.08.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PAHC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup - Reiterated
Neutral → Neutral 2026-05-14 Building track record
Citigroup ● Initiated
Neutral 2026-04-15 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2025-11-07 43% win rate (7 calls)
B of A Securities - Reiterated
Underperform → Underperform 2025-08-29 Building track record
JP Morgan ↑ Upgrade
Neutral → Overweight 2025-07-07 43% win rate (7 calls)
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2025-06-25 Building track record
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2025-05-08 Building track record
Barclays - Reiterated
Underweight → Underweight 2025-02-10 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
33
out of 100
Coverage depth
14/30
Consensus clarity
17/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →